Effects of azeliragon on ADAS‐cog and CDR domains and individual items in patients with mild Alzheimer's disease and type 2 diabetes (T2D): Human/Human trials: Other. - Burstein, Aaron H.; Dunn, Imogene; Gooch, Ann M.; Valcarce, Carmen (Alzheimer's & dementia: the journal of the Alzheimer's Association, 2020)